Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/8/22 08:01 | 7/6/22 | NMTR | Health | Drug | Pharmaceutical Preparations | Temperato John | NC | DO | CEO | P | 28 | 0.2277 | 0 | 125 | 10 | 1,428 | D | ||||||||||||||
7/6/22 16:43 | 7/1/22 | NMTR | Health | Drug | Pharmaceutical Preparations | Sirgo Mark A | NC | D | P | 43 | 0.2455 | 0 | 175 | 13 | 1,476 | D | |||||||||||||||
5/24/22 16:01 | 5/23/22 | NMTR | Health | Drug | Pharmaceutical Preparations | Constantino Michael T. | NC | D | P | 8 | 0.4755 | 0 | 16 | 36 | 61 | D | |||||||||||||||
5/19/22 16:09 | 5/18/22 | NMTR | Health | Drug | Pharmaceutical Preparations | Temperato John | NC | DO | CEO | P | 22 | 0.4457 | 0 | 50 | 4 | 1,303 | D | ||||||||||||||
5/19/22 16:01 | 5/18/22 | NMTR | Health | Drug | Pharmaceutical Preparations | Sirgo Mark A | NC | D | P | 50 | 0.4700 | 0 | 106 | 8 | 1,407 | D | |||||||||||||||
3/21/22 16:17 | 8/20/20 | NMTR | Health | Drug | Pharmaceutical Preparations | Constantino Michael T. | NC | D | P.a | 20 | 0.7545 | 0 | 27 | New | 27 | D | |||||||||||||||
3/7/22 08:01 | 3/3/22 | NMTR | Health | Drug | Pharmaceutical Preparations | Sirgo Mark A | NC | D | P | 50 | 0.5784 | 0 | 86 | 7 | 1,301 | D | |||||||||||||||
3/4/22 08:00 | 3/3/22 | NMTR | Health | Drug | Pharmaceutical Preparations | Temperato John | NC | DO | CEO | P | 56 | 0.5559 | 0 | 100 | 9 | 1,253 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |